Education
About Us
Working with TipRanks
Follow Us
Viveve Medical (VIVE)
:VIVE
Total Valuation
Viveve Medical has a market cap or net worth of $1.07K. The enterprise value is $115.01B.
Market Cap$1.07K
Enterprise Value$115.01B
Share Statistics
Viveve Medical has 10,723,857 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,723,857
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Viveve Medical’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -100.93%.
Return on Equity (ROE)-1.46
Return on Assets (ROA)-0.85
Return on Invested Capital (ROIC)-100.93%
Return on Capital Employed (ROCE)-1.01
Revenue Per Employee136.72K
Profits Per Employee-468.66K
Employee Count47
Asset Turnover0.25
Inventory Turnover3.94
Valuation Ratios
The current PE Ratio of Viveve Medical is -5.22K. Viveve Medical’s PEG ratio is 64.97.
PE Ratio-5.22K
PS Ratio0.00
PB Ratio7.63K
Price to Fair Value7.63K
Price to FCF-8.63K
Price to Operating Cash Flow-8.93K
PEG Ratio64.97
Income Statement
In the last 12 months, Viveve Medical had revenue of 6.43M and earned -22.03M in profits. Earnings per share was -2.65.
Revenue6.43M
Gross Profit620.00K
Operating Income-21.55M
Pretax Income-21.77M
Net Income-22.03M
EBITDA-19.63M
Earnings Per Share (EPS)-2.65
Cash Flow
In the last 12 months, operating cash flow was -16.23M and capital expenditures -595.00K, giving a free cash flow of -16.83M billion.
Operating Cash Flow-16.23M
Free Cash Flow-16.83M
Free Cash Flow per Share-1.57
Dividends & Yields
Viveve Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta245.60
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)2.35K
Important Dates
Viveve Medical upcoming earnings date is Nov 9, 2023, TBA Not Confirmed.
Last Earnings DateAug 10, 2023
Next Earnings DateNov 9, 2023
Ex-Dividend Date―
Financial Position
Viveve Medical as a current ratio of 4.91, with Debt / Equity ratio of 35.50%
Current Ratio4.91
Quick Ratio4.58
Debt to Market Cap<0.01
Net Debt to EBITDA0.70
Interest Coverage Ratio-21.55
Taxes
In the past 12 months, Viveve Medical has paid 256.00K in taxes.
Income Tax256.00K
Effective Tax Rate-0.01
Enterprise Valuation
Viveve Medical EV to EBITDA ratio is -5.86K, with an EV/FCF ratio of -8.63K.
EV to Sales17.90K
EV to EBITDA-5.86K
EV to Free Cash Flow-8.63K
EV to Operating Cash Flow-8.93K
Balance Sheet
Viveve Medical has $5.91M in cash and marketable securities with $5.88M in debt, giving a net cash position of -$26.00K billion.
Cash & Marketable Securities$5.91M
Total Debt$5.88M
Net Cash-$26.00K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$1.49
Margins
Gross margin is 9.65%, with operating margin of -335.40%, and net profit margin of -342.78%.
Gross Margin9.65%
Operating Margin-335.40%
Pretax Margin-338.80%
Net Profit Margin-342.78%
EBITDA Margin-305.51%
EBIT Margin-323.23%
Analyst Forecast
The average price target for Viveve Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―